# FDA 483 - Corden Pharma S.p.A. - July 15, 2016

Source: https://www.globalkeysolutions.net/records/483/corden-pharma-spa/30a951db-d279-4ffd-8b14-95a83d8dbe1b

> FDA 483 for Corden Pharma S.p.A. on July 15, 2016. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: Corden Pharma S.p.A.
- Inspection Date: 2016-07-15
- Product Type: drugs
- Office Name: International Compliance Team
- Summary: During an inspection from July 7-15, 2016, the FDA observed significant deficiencies at Corden Pharma S.p.A. in Caponago, Italy, a drug manufacturer. The findings primarily concern inadequate laboratory controls, including unvalidated test methods and incomplete records, as well as issues with facility maintenance, personnel gowning, and quality system investigations into product complaints. These observations indicate a lack of adherence to good manufacturing practices.

## Related Documents

- [483 - 2026-10-18](https://www.globalkeysolutions.net/records/483/corden-pharma-spa/164f8f02-3ada-4a12-8708-897de183dd48)

## Related Officers

- [investigator](https://www.globalkeysolutions.net/people/xiaoping-guan/191018c9-9f60-4db0-a9eb-48314b53e515)
- [SVP Consulting & Operations](https://www.globalkeysolutions.net/people/linda-f-murphy/a8b9737f-d5f4-4a36-8684-2fb050d008f2)

Company: https://www.globalkeysolutions.net/companies/corden-pharma-spa/9ebac113-b666-42f4-bce9-0183154975f3

Office: https://www.globalkeysolutions.net/offices/international-compliance-team/f0ce0d89-bf39-46c6-8c42-28138d161321